Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417)

ClinicalTrials.gov ID: NCT00305487

Public ClinicalTrials.gov record NCT00305487. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 5:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Clinical Trial Designed to Assess the Safety and Efficacy of Ciclesonide (200mcg and 100mcg, Once Daily) Applied as a Nasal Spray for Two Weeks in the Treatment of Seasonal Allergic Rhinitis (SAR) in Patients 6 to 11 Years of Age

Study identification

NCT ID
NCT00305487
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
660 participants

Conditions and interventions

Interventions

  • Ciclesonide nasal spray Drug

Drug

Eligibility (public fields only)

Age range
6 Years to 11 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2006
Primary completion
Sep 30, 2006
Completion
Sep 30, 2006
Last update posted
Nov 29, 2016

2006

United States locations

U.S. sites
71
U.S. states
28
U.S. cities
68
Facility City State ZIP Site status
Altana Pharma/Nycomed Birmingham Alabama 35235
Altana Pharma/Nycomed Hot Springs Arkansas 71913
Altana Pharma/Nycomed Costa Mesa California 92626
Altana Pharma/Nycomed Huntington Beach California 92647
Altana Pharma/Nycomed Long Beach California 90806
Altana Pharma/Nycomed Los Alamitos California 90720
Altana Pharma/Nycomed Mission Viejo California 92691
Altana Pharma/Nycomed Orange California 92868
Altana Pharma/Nycomed Roseville California 95678
Altana Pharma/Nycomed San Diego California 92120
Altana Pharma/Nycomed San Diego California 92123
Altana Pharma/Nycomed San Jose California 95117
Altana Pharma/Nycomed Stockton California 95207
Altana Pharma/Nycomed Colorado Springs Colorado 80907
Altana Pharma/Nycomed Denver Colorado 80230
Altana Pharma/Nycomed Englewood Colorado 80112
Altana Pharma/Nycomed Lakewood, CO Colorado 80401
Altana Pharma/Nycomed Atlanta Georgia 30342
Altana Pharma/Nycomed Gainesville Georgia 30501
Altana Pharma/Nycomed Savannah Georgia 31406
Altana Pharma/Nycomed Woodstock, GA Georgia 30188
Altana Pharma/Nycomed Normal Illinois 61761
Altana Pharma/Nycomed Indianapolis Indiana 46208
Altana Pharma/Nycomed Overland Park Kansas 66211
Altana Pharma/Nycomed Louisville, KY Kentucky 40215
Altana Pharma/Nycomed Metairie Louisiana 70006
Altana Pharma/Nycomed Shreveport Louisiana 71105
Altana Pharma/Nycomed Bethesda Maryland 20814
Altana Pharma/Nycomed North Dartmouth Massachusetts 02747
Altana Pharma/Nycomed Minneapolis Minnesota 55402
Altana Pharma/Nycomed Jefferson City Missouri 65109
Altana Pharma/Nycomed Rolla Missouri 65401
Altana Pharma/Nycomed St Louis Missouri 63141
Altana Pharma/Nycomed Lincoln, NE Nebraska 68505
Altana Pharma/Nycomed Papillion Nebraska 68046
Altana Pharma/Nycomed Brick New Jersey 08724
Altana Pharma/Nycomed Forked River New Jersey 08731
Altana Pharma/Nycomed Red Bank New Jersey 07701
Altana Pharma/Nycomed Skillman New Jersey 08558
Altana Pharma/Nycomed Warren Township New Jersey 07059
Altana Pharma/Nycomed Rochester, NY New York 14618
Altana Pharma/Nycomed Rockville Centre New York 11570
Altana Pharma/Nycomed Raleigh North Carolina 27607
Altana Pharma/Nycomed Cincinnati Ohio 45219
Altana Pharma/Nycomed Cincinnati, OH Ohio 45231
Altana Pharma/Nycomed Ashland Oregon 97520
Altana Pharma/Nycomed Lake Oswego Oregon 97035
Altana Pharma/Nycomed Medford, OR Oregon 97504
Altana Pharma/Nycomed Portland Oregon 97213
Altana Pharma/Nycomed Blue Bell Pennsylvania 19422
Altana Pharma/Nycomed Eerie Pennsylvania 16506
Altana Pharma/Nycomed Pittsburgh Pennsylvania 15202
Altana Pharma/Nycomed Pittsburgh Pennsylvania 15241
Altana Pharma/Nycomed Upland Pennsylvania 19013
Altana Pharma/Nycomed Charleston South Carolina 29414
Altana Pharma/Nycomed Charleston, SC South Carolina 29407
Altana Pharma/Nycomed Germantown Tennessee 38138
Altana Pharma/Nycomed Jackson Tennessee 38301
Altana Pharma/Nycomed Austin Texas 78731
Altana Pharma/Nycomed Austin Texas 78750
Altana Pharma/Nycomed Dallas Texas 75231
Altana Pharma/Nycomed El Paso Texas 79925
Altana Pharma/Nycomed Kerrville Texas 78028
Altana Pharma/Nycomed New Braunfels Texas 78130
Altana Pharma/Nycomed San Antonio Texas 78229
Altana Pharma/Nycomed Salt Lake City Utah 84037
Altana Pharma/Nycomed South Burlington Vermont 05403
Altana Pharma/Nycomed Burke Virginia 22015
Altana Pharma/Nycomed Charlottesville Virginia 22911
Altana Pharma/Nycomed Richmond Virginia 23226
Altana Pharma/Nycomed Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00305487, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 29, 2016 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00305487 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →